Interestingly, we observed an enrichment of genes associated with a loss of TP53 signaling in poorly differentiated tumor foci compared to adenocarcinoma despite no distinguishing loss of function mutations or change in Trp53 expression (Supplementary Fig. 3a, c, d). The gene discussed is TP53; the disease is adenocarcinoma.